Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study

Added 63 days ago (22.07.2021)
Authors: Marja K. Puurunen; Jerry Vockley; Shawn L. Searle; Stephanie J. Sacharow; John A. Phillips III; William S. Denney; Benjamin D. Goodlett; David A. Wagner; Larry Blankstein; Mary J. Castillo; Mark R. Charbonneau; Vincent M. Isabella; Vasu V. Sethuraman; Richard J. Riese; Caroline B. Kurtz; Aoife M. Brennan
Read article